Showing results (11-20 of 88) with videos related to
Sort By:
Pageof 9
Chemmedchem|July 9, 2016
Discovery of Highly Potent Dual Orexin Receptor Antagonists via a Scaffold-Hopping ApproachBibia Heidmann, John Gatfield, Catherine Roch, et al.Bioorganic & Medicinal Chemistry Letters|April 4, 2015
Substituted pyrrolidin-2-ones: Centrally acting orexin receptor antagonists promoting sleep. Part 2Thierry Sifferlen, Amandine Boller, Audrey Chardonneau, et al.Bioorganic & Medicinal Chemistry Letters|June 21, 2016
From bosentan (Tracleer®) to macitentan (Opsumit®): The medicinal chemistry perspectiveChristoph Boss, Martin H Bolli, John GatfieldChemmedchem|August 23, 2014
Structure-activity relationship, biological, and pharmacological characterization of the proline sulfonamide ACT-462206: a potent, brain-penetrant dual orexin 1/orexin 2 receptor antagonistChristoph Boss, Catherine Roch-Brisbare, Michel A Steiner, et al.Journal of Sleep Research|April 22, 2023
The orexin story and orexin receptor antagonists for the treatment of insomniaClemens Muehlan, Catherine Roch, Cedric Vaillant, et al.Dalton Transactions (Cambridge, England : 2003)|May 22, 2013
Cationic D4R zinc phosphate-anionic polyoxometalate hybrids: synthesis, spectra, structure and catalytic studiesAlok Ch Kalita, Catherine Roch-Marchal, Ramaswamy MurugavelPsychopharmacology|August 20, 2021
Nonclinical pharmacology of daridorexant: a new dual orexin receptor antagonist for the treatment of insomniaCatherine Roch, Giorgio Bergamini, Michel A Steiner, et al.Epilepsia|April 16, 2002
Magnetic resonance imaging in the study of the lithium-pilocarpine model of temporal lobe epilepsy in adult ratsCatherine Roch, Claire Leroy, Astrid Nehlig, et al.Epilepsia|October 9, 2002
Predictive value of cortical injury for the development of temporal lobe epilepsy in 21-day-old rats: an MRI approach using the lithium-pilocarpine modelCatherine Roch, Claire Leroy, Astrid Nehlig, et al.Pageof 9